BPC-157 (short for Body Protection Compound-157) is a synthetic peptide derived from a protective protein found in gastric juice
A differential for the myelopathy would include various metabolic, toxic, immunologic, and infectious disorders, such as copper deficiency myelopathy (possibly precipitated by zinc toxicity), folate deficiency myelopathy, vitamin E deficiency myelopathy, nitrous oxide toxicity, HIV-related vacuolar myelopathy, HTLV-1-associated myelopathy, neurosyphilis, and possibly Lyme disease
Currently, the standard of care does not include injecting or prescribing unapproved experimental peptides for injuries there is no FDA approval or authoritative guideline endorsing BPC-157 use
For laboratory use, it may be reconstituted with bacteriostatic water or another appropriate solvent according to established research protocols
They work with the body rather than against it
Cancer Research has shown that folate deficiency can increase your risk of some cancers, such as colon cancer